Pseudohypoparathyroidism secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Mazia Fatima (talk | contribs) No edit summary |
Mazia Fatima (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{Mazia}} | {{CMG}}; {{AE}}{{Mazia}} | ||
==Overview== | ==Overview== | ||
Secondary prevention | Secondary prevention measures in pseudohypoparathyroidism include regular serum and urinary [[calcium]] measurements monitoring. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Secondary prevention measures in pseudohypoparathyroidism include : | Secondary prevention measures in pseudohypoparathyroidism include : | ||
* Monitor therapy with regular serum and urinary [[calcium]] measurements. | * Monitor therapy with regular serum and urinary [[calcium]] measurements. | ||
* Pseudohypoparathyroidism type 1b patients at an increased risk of developing [[hyperparathyroidism]] and [[hyperparathyroid]] bone disease should be maintained at sufficient doses of [[calcium]] and [[vitamin D]] to maintain serum [[calcium]] and [[PTH]] levels within the normal range. | * Pseudohypoparathyroidism type 1b patients at an increased risk of developing [[hyperparathyroidism]] and [[hyperparathyroid]] bone disease should be maintained at sufficient doses of [[calcium]] and [[vitamin D]] to maintain serum [[calcium]] and [[PTH]] levels within the normal range. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:20, 29 September 2017
|
Pseudohypoparathyroidism Microchapters |
|
Differentiating Pseudohypoparathyroidism from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pseudohypoparathyroidism secondary prevention On the Web |
|
American Roentgen Ray Society Images of Pseudohypoparathyroidism secondary prevention |
|
Risk calculators and risk factors for Pseudohypoparathyroidism secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]
Overview
Secondary prevention measures in pseudohypoparathyroidism include regular serum and urinary calcium measurements monitoring.
Secondary Prevention
Secondary prevention measures in pseudohypoparathyroidism include :
- Monitor therapy with regular serum and urinary calcium measurements.
- Pseudohypoparathyroidism type 1b patients at an increased risk of developing hyperparathyroidism and hyperparathyroid bone disease should be maintained at sufficient doses of calcium and vitamin D to maintain serum calcium and PTH levels within the normal range.